chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started having symptoms of Covid 11/30/2021. They day after thanksgiving I had a family dinner ay my house. There were 9 people and my niece was complaining of a headache but is not unusual for her. Her son had a low-grade temperature. I never thought about it being Covid. Everybody that was at my house for that dinner tested positive for Covid. We got the results that they tested positive on Sunday. On Tuesday afternoon which was 11/30/2021 I got really dizzy and lightheaded and I sat down in my desk. I felt like I was going to vomit. I was at the bathroom vomiting and with diarrhea at the same time. The nurse came in and they wanted me to leave. But I was too sick and I could not drive like that. I called my doctor and I had a telehealth visit. They wanted me to come in so I went and they did a rapid test which came back negative. They also did a PCR test which 2 days later came back positive. I ran a high fever of 102 and over. The highest was 104.7. I had a headache and nausea. I had another telehealth visit on Friday because the fever would not stop. Then they refereed me to get the immunoglobin therapy Regeneron. On Monday I got the infusion. That afternoon I felt very tired but my symptoms alleviated. On Tuesday I felt much better. Wednesday morning I felt better. Thursday I started having like respiratory problems and GI symptoms. That Friday I ended up in urgent care and they did chest x-rays and diagnosed me with Covid pneumonia. I took Trelegy inhaler which helped me a lot with the pneumonia and I also did nebulizing treatments. I had to take 2 rounds of steroids. I started with the high temperatures again. The health department and my doctor had me in isolation until 12/23/2021 because I was still having symptoms. I had fever, shortness of breath with exertion, nausea, dizziness, and cough. After 12/23 I stopped having temperatures but I started having muscle aches, which I never had. I went back to work on 01/05/2022 and I was not feeling 100% but I was feeling better. Since then, I have had problems with joint and muscle pain and leg swelling. From 01/12/2022 through 01/17/2022 I had a high fever and a headache and they never figured out what it was. It was about 103+. Went to the doctor for that and they tested me for Covid again. It came back negative. My leg swelling was so and they thought I had blood clots. They did some lab work and it came back negative. Now they think I have chronic Covid-19 syndrome. I have another doctors appointment on Tuesday to follow up. I went back to work. I do not feel 100%. I still have the leg pain and swelling and muscle pain.
Pt received both shots in left arm evening of 9/4. Returned to pharmacy morning with painful, swollen, red, warm arm. Affected are reached from shoulder to elbow. Pt saw his provider and was advised to use ice, elevation and NSAIDS to treat.
10 mcg dose of Pfizer Covid Vaccine given to 15 year old patient at 5:14 pm. Error discovered within 5 minutes of dose given. Division supervisor referred to standing orders and discussed with lead pharmacist. Deviation of 10 mcg dose given to age 12 or greater requires action of repeating with 30 mcg dose as soon as possible. Discussed error with patient and both parents and they agreed to receive appropriate dose of 30 mcg which was given at 5:44 pm . Client waited in post vaccination area for 30 minutes after receiving 30 mcg dose. No adverse reactions observed or reported.
Complaint for headache, sore back, chills - not severe, but did not eat supper, and went to bed with extra blankets, in bed resting
The back and shoulders were hurting; I felt like I had the flu; I had such a body ache that I had to get up; The back and shoulders were hurting; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (The back and shoulders were hurting), INFLUENZA LIKE ILLNESS (I felt like I had the flu), MYALGIA (I had such a body ache that I had to get up) and ARTHRALGIA (The back and shoulders were hurting) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History.  Concomitant products included METFORMIN, FINASTERIDE, PRAVASTATIN, CARVEDILOL, ISOSORBIDE, FENOFIBRATE, RAMIPRIL and INSULIN for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced BACK PAIN (The back and shoulders were hurting), INFLUENZA LIKE ILLNESS (I felt like I had the flu), MYALGIA (I had such a body ache that I had to get up) and ARTHRALGIA (The back and shoulders were hurting). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 01-Mar-2021, INFLUENZA LIKE ILLNESS (I felt like I had the flu) had resolved. At the time of the report, BACK PAIN (The back and shoulders were hurting), MYALGIA (I had such a body ache that I had to get up) and ARTHRALGIA (The back and shoulders were hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication included Tylenol. 2-3 minutes after taking it, the pain was gone. He says this was coincidental, and not due to the Tylenol (can't act that quick, he said).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up received on 25-May-2021 contains no new information-patient denied further follow up.
urticaria, erythema, and puritis of deltoid area of left arm at injection site
headache; body aches; light headed; This is a spontaneous report from a contactable consumer. An adult male patient received bnt162b2 (UNSPECIFIED TRADE NAME, Solution for injection), dose 2 via an unspecified route of administration on 04Feb2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient' medical history was not reported. There were no concomitant medications. Facility type Vaccine was Pharmacy or Drug Store. No Other vaccine in four weeks. The patient received 2nd dose of vaccine in am, in pm had headache. Woke following am with body aches and light headed. Symptoms resolved over the course of the day. Adverse events started date was 04Feb2021. No treatment for the events. No Covid prior vaccination. No covid tested post vaccination. The outcome of the events was recovered in Feb2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from an 81 year old female who in October 2008 was vaccinated with ZOSTAVAX (Oka/Merck), 0.65ml/once, SC Subsequently the patient developed shingles since vaccination. The patient sought medical attention. Additional information has been requested.
13 year old male new to our clinic here with MGM for vaccines in MA visit. He received MCV4 and Tdap for an MA visit. After the MA visit, child was exiting room with MGM. He stopped in the hallway and suddenly fell forward, landing on his chin. He did not extend his arms to catch himself from the fall. The fall was witness by MA. After child fell, I was called from a room and came to child within a few seconds from the fall. When I arrived, he had been moved over to his back and was not responding. He was noted to be bleeding from a chin laceration that was approx 4 cm wide and deep enough to see the bone of the mandible. Pressure was applied to the bleeding. Child was tense and posturing for approx 5 seconds. He then regained consciousness and was not able to say where he was for approx 20 -30 seconds. A blood pressure cuff was placed on the right arm and BP was initially 83/52 with a HR in the 50's. O2 saturations were in the mid 90's. Within about 30 seconds, child was able to state his full name, state his location, and talk to his MGM. He was intermittently falling asleep with his eyes rolling back in his head. Given his LOC and significant laceration in addition to the mechanism of the fall, I opted to call EMS and have child transported to MC for further care and assessment. C-spine was held until EMS arrived. Repeat BP prior to EMS arrival was 96/63, HR in the 60's. O2 saturations in the mid 90's. He was placed on 0.5 L of mask O2 and pressure continued to be held on chin laceration. Upon arrival of EMS, child was alert and oriented, but sleepy. He did not want to open his mouth and complained of mouth and jaw pain. EMS sat child up and released him from C-spine. They recommended transport to MC in private vehicle; however, child's GM did not have a car and requested ambulance transport.
STERILE WATER FOR INJECTION WAS MIXED AS DILUENT NO ADVERSE REACTION REPORTED AT TIME OF THIS REPORT
mom reported pt had sz the noc recv vax;sx occurred about 1hr p/vax lasted 5min;
This case was reported by a physician via a representative and described the occurrence of fever in a 1-year-old male subject who was vaccinated with HAVRIX (GlaxoSmithKline). On 9 April 2007, the subject received unspecified dose of HAVRIX (unknown). On 10 April 2007, 24 hours after vaccination with HAVRIX, the subject experienced fever. He was taken to the emergency room by ambulance. He was not admitted. The subject was seen on 11 April 2007 by his physician and was reportedly doing fine. The child did not require additional medicine or treatments. No further information was available. At the time of reporting the outcome of the event was unspecified. Follow-up information was received on 23 July 2007 via a physician, who reported that the subject experienced a febrile seizure on 10 April 2007. The physician indicated that the subject was hospitalized (duration unspecified). The HAVRIX immunization series was discontinued. The reporting physician considered the febrile convulsion to be possibly related to vaccination with HAVRIX, but also indicated that the event was possibly associated with the subject's medical history/concurrent illness (unspecified). At the time of reporting, the febrile seizure was resolved. Follow up information was received on 01 October 2007 via the physician, who reported that the febrile seizure was witnessed and was accompanied by loss of consciousness. It was uncertain whether the seizure was preceded by an aura or headache, or whether the seizure was accompanied by urine or fecal incontinence due to the subject's wearing of a diaper. All events resolved/resolved with sequelae on 10 April 2007, and the physician indicated that the HAVRIX vaccination series was discontinued "for now". The physician further indicated that the event was not serious, and that there was no planned follow up for the event.
Numbness and partial paralysis in both arms, severe pain in left arm and neck, muscle weakness in both legs, difficulty catching breath.
Pt was vaccinated with PNEUMOVAX 23. Pt was tx in the ER due to the development of a scab producing lesion and potentially cellulitis. Similar to that of smallpox vaccine.
Severe fever of 105F for over 3 days plus low-grade fever for another 2 days. Severe discomfort and lethargy.
Asthma attack- symptoms of cough and perceived wheezing. steadily improved during obs period.
Hives started at right arm of injection site. Moved down right side of chest and stomach next morning.
Urticaria. Swelling of left forearm and face. Rash on both arms, face and upper body. Treated with PredniSONE 20 mg 2 tablets for 4 days, 1 tablet for 3 days 1 ZYRTEC daily cleared in 4 days.
This spontaneous report has been received from a registered nurse refers to an unspecified patient of unknown age and gender. There was not information regarding pertinent medical history, drug reaction or concomitant therapies. On an unknown date, the patient was vaccinated with an improperly stored ROTATEQ, oral, (dose and frequency were not provided) with  lot # M002254, and expiration date 15-NOV-2017 for prophylaxis, or ROTATEQ with lot# M016238 and expiration date 07-DEC-2017. The reporter stated that the temperature range of the vaccine was 32F and 36F and the time frame was 24 hours, also she stated that there was not previous temperature excursion, this information was administered in a data logger. No adverse effect was reported. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA000713: US-009507513-1612USA014621.
Plaques; achy joints; could not eat gluten without getting sick; Bloody nose; Dry nose; Sinus congestion; Scratchy throat; Head cold; Pneumonia; This is a solicited report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 21K-163-3950656-00.  A 43-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) intramuscular for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown); adalimumab (HUMIRA), on 15Mar2019 as unk (citrate free) (Batch/Lot number: unknown) subcutaneous for psoriatic arthropathy, psoriasis. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NASOPHARYNGITIS (non-serious) with onset Jun2021, outcome "not recovered", described as "Head cold"; PNEUMONIA (medically significant) with onset Jun2021, outcome "not recovered"; THROAT IRRITATION (non-serious) with onset Oct2021, outcome "recovering", described as "Scratchy throat"; PSORIASIS (non-serious), outcome "unknown", described as "Plaques"; ARTHRALGIA (non-serious), outcome "recovered", described as "achy joints"; GLUTEN SENSITIVITY (non-serious), outcome "unknown", described as "could not eat gluten without getting sick"; EPISTAXIS (non-serious), outcome "unknown", described as "Bloody nose"; NASAL DRYNESS (non-serious), outcome "unknown", described as "Dry nose"; SINUS CONGESTION (non-serious), outcome "unknown".  The reporter's assessment of the causal relationship of "pneumonia", "plaques", "achy joints", "could not eat gluten without getting sick", "bloody nose", "dry nose", "scratchy throat", "head cold" and "sinus congestion" with the suspect product(s) BNT162b2 was not provided at the time of this report. Since no determination has been received, the case is managed based on the company causality assessment.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the information in the case report, a possible causal relationship between reported events and suspect drug BNT162B2 cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate
Shots are mildly painful in arm; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of pain in extremity (received 1st dose on an unknown date. For the tolerance of 1st dose, refer linked case US2021AMR103686).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.  Additional details were provided as follows: The reporter had reported for him/herself. The age group was not reported but was captured as an adult as per the vaccine indication. The age at vaccination was not reported. The patient stated that, the shingles shot was mildly painful in arm for four days but better than shingles.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR103686:1st dose
Arm swollen from injection site to almost elbow. Itchy, hot to touch, arm sore.
p/vax pt devel fever 39C @ home;APAP given & fever dec;T38.5;rt deltoid below incision warm, tender w/diffuse erythema;fever/pain;DPH given for itching;
Patient was given the second dose of Meningo in error.  Had already received it from another provider.  No adverse effects observed or reported.
Chills. Tired. Body very cold. Equalibrium, driving, and brain function decrease. Throat hourse. No fever, no body aches, but body felt "twingy". 10/23 ER found nothing wrong same with PDr. 10/28.
Rash; Itching; This case was reported by a physician via call center representative and described the occurrence of papular rash in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, 28 days after receiving Shingrix, the patient experienced papular rash and pruritus. On an unknown date, the outcome of the papular rash and pruritus were unknown.   It was unknown if the reporter considered the papular rash and pruritus to be related to Shingrix.  Additional details were provided as follows: The age at vacciantion was not reported. The reporter asked if anyone could get a chicken pox or shingles rash from the vaccine 4 to 6 weeks out. The patient had a non blister but papular rash bilaterally inner arms, itchy a few days timing was 4 weeks out from injection. The reporter consented to follow up. Probed for administration date and dose number but visitor disconnected from the chat.
When the shot was administered, some of the liquid leaked out of the arm and ran down his arm to the elbow.  The immunizer  was unable to determine how much of the shot was injected. She conferred with the pharmacy manager who said that it was okay and that nothing more could be done.  The next day, I called the pharmacy and spoke to the immunizer who said that it leaked out after she took out the syringe and that at least two drops came out. She thinks that more than half went in but can't be sure. She was not sure why it happened. The following day, I called again and spoke to the manager who stated that it is too hard to estimate how many drops are in a full dose of .2mL and that generally they don't give another half shot or full shot to complete the dosage. He suggested that I could get an antibody test, but that they would not cover the cost of that expense.  He said that he was "pretty sure" that he got enough of the shot, but he was not present at the time of the administration of the shot.    I called the Health Department and the medical director stated, ?If there is a lower than authorized dose, it would be repeated. It's hard to know how much leaked out so I can't recommend if they should repeat and would defer to the person who administered. The rule of thumb had been if more than half leaked out to repeat but the new guidelines are less clear.  If I had administered and a substantial portion had leaked (even if less than half), I would repeat but I don?t have an understanding of the amount.  For example, if it?s a drop and you repeat, you would then provide a larger than authorized dose."  The patient did not experience any of the side effects that he experience after the first dose - no arm soreness, fatigue, low fever, etc.  He did have  large, circular bruise on his arm for 6 days and a puncture hole for 2 days.  This was not present after receiving the first shot.  My suspicion is that the immunizer injected him too quickly and with too much pressure, then depressed the plunger too quickly and it leaked when she pulled out.
arm soreness , dizziness, nausea, headache, new onset cough , body ache, chills, low grade fever
Suspect COVID breakthrough case s/p fall- intracranial bleed and was found to be incidentally COVID positive
Information has been received from a physician concerning a 24 month old male who on 19-MAR-2009 was vaccinated with a dose of MMR II (lot# was not provided). The patient experienced hives at the injection site two weeks later the administration date of MMR II and VARIVAX (Merck). The patient sought unspecified medical attention. On an unspecified date the patient was recovered. Additional information has been requested.
I woke up this morning with painful, swollen lymph nodes in my left arm.  It is still going on into the evening and seems to be increasing in severity.
had the shot and still got shingles 6 more times \ Suspected Vaccination failure; got shingles 6 more times; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The physician told the reporter that she had Shingles shot and still got shingles 6 more times. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
VACCINE DRAWN UP IN SYRINGE POSSIBLY ADMINISTERED PAST THE 6 HOUR EXPIRATION; This spontaneous report received from a pharmacist . The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 04-MAY-2021, the subject experienced vaccine drawn up in syringe possibly administered past the 6 hour expiration. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of vaccine drawn up in syringe possibly administered past the 6 hour expiration was not reported. This report was non-serious.
2 days developed fever to 102, muscle aches, pharyngitis, and laryngitis.
In bed sick; Runny nose; Fever; Aches; Headache; Fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (In bed sick), RHINORRHOEA (Runny nose), PYREXIA (Fever), MYALGIA (Aches) and HEADACHE (Headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Aug-2021, the patient experienced ILLNESS (In bed sick), RHINORRHOEA (Runny nose), PYREXIA (Fever), MYALGIA (Aches), HEADACHE (Headache) and FATIGUE (Fatigue). At the time of the report, ILLNESS (In bed sick), RHINORRHOEA (Runny nose), PYREXIA (Fever), MYALGIA (Aches), HEADACHE (Headache) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment medications were not provided by the reporter.